skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 184,144  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page
Refined by: Journal Title: Bmj remove
Result Number Material Type Add to My Shelf Action Record Details and Options
21
Covid-19: risk factors for severe disease and death
Covid-19: risk factors for severe disease and death
Material Type:
Article 		Add to My Research

Covid-19: risk factors for severe disease and death

BMJ (Online), 2020-03, Vol.368, p.m1198-m1198 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m1198 ;PMID: 32217618

Full text available

Citations Cited by
22
Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports
Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports
Material Type:
Article 		Add to My Research

Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports

BMJ (Online), 2021-11, Vol.375, p.n2713-n2713 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2021BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n2713 ;PMID: 34750163

Full text available

Citations Cited by
23
Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction
Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction
Material Type:
Article 		Add to My Research

Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction

BMJ (Online), 2020-03, Vol.368, p.m1036-m1036 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m1036 ;PMID: 32165426

Full text available

Citations Cited by
24
China coronavirus: what do we know so far?
China coronavirus: what do we know so far?
Material Type:
Article 		Add to My Research

China coronavirus: what do we know so far?

BMJ (Online), 2020-01, Vol.368, p.m308-m308 [Peer Reviewed Journal]

ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m308 ;PMID: 31980434

Full text available

Citations Cited by
25
National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study
National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study
Material Type:
Article 		Add to My Research

National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study

BMJ (Online), 2020-05, Vol.369, p.m1590-m1590 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m1590 ;PMID: 32467098

Full text available

Citations Cited by
26
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies
Material Type:
Article 		Add to My Research

Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies

BMJ (Online), 2020-03, Vol.368, p.m689-m689 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m689 ;PMID: 32213531

Full text available

Citations Cited by
27
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

BMJ (Online), 2022-03, Vol.376, p.e068632-e068632 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2021-068632 ;PMID: 35236664

Full text available

Citations Cited by
28
Revisiting the timetable of tuberculosis
Revisiting the timetable of tuberculosis
Material Type:
Article 		Add to My Research

Revisiting the timetable of tuberculosis

BMJ (Online), 2018-08, Vol.362, p.k2738-k2738 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2018 BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k2738 ;PMID: 30139910

Full text available

Citations Cited by
29
Covid-19: four fifths of cases are asymptomatic, China figures indicate
Covid-19: four fifths of cases are asymptomatic, China figures indicate
Material Type:
Article 		Add to My Research

Covid-19: four fifths of cases are asymptomatic, China figures indicate

BMJ (Online), 2020-04, Vol.369, p.m1375-m1375 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m1375 ;PMID: 32241884

Full text available

Citations Cited by
30
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
Material Type:
Article 		Add to My Research

Covid-19: FDA approves use of convalescent plasma to treat critically ill patients

BMJ (Online), 2020-03, Vol.368, p.m1256-m1256 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m1256 ;PMID: 32217555

Full text available

Citations Cited by
31
Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies
Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies
Material Type:
Article 		Add to My Research

Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies

BMJ (Online), 2016-09, Vol.354, p.i5065-i5065 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright BMJ Publishing Group LTD Sep 28, 2016 ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2016 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i5065 ;PMID: 27683072

Full text available

Citations Cited by
32
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Material Type:
Article 		Add to My Research

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

BMJ (Online), 2021-03, Vol.372, p.n71-n71 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n71 ;PMID: 33782057

Full text available

Citations Cited by
33
Dexamethasone in the management of covid -19
Dexamethasone in the management of covid -19
Material Type:
Article 		Add to My Research

Dexamethasone in the management of covid -19

BMJ (Online), 2020-07, Vol.370, p.m2648-m2648 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m2648

Full text available

Citations Cited by
34
Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear
Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear
Material Type:
Article 		Add to My Research

Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear

BMJ (Online), 2021-11, Vol.375, p.n2943-n2943 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n2943 ;PMID: 34845008

Full text available

Citations Cited by
35
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
Material Type:
Article 		Add to My Research

A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance

BMJ (Online), 2021-09, Vol.374, p.n2061-n2061 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n2061 ;PMID: 34593508

Full text available

Citations Cited by
36
Particulate air pollution and mortality in 38 of China’s largest cities: time series analysis
Particulate air pollution and mortality in 38 of China’s largest cities: time series analysis
Material Type:
Article 		Add to My Research

Particulate air pollution and mortality in 38 of China’s largest cities: time series analysis

BMJ (Online), 2017-03, Vol.356, p.j667-j667 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2017 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.j667 ;PMID: 28292780

Full text available

Citations Cited by
37
Covid-19: What do we know about “long covid”?
Covid-19: What do we know about “long covid”?
Material Type:
Article 		Add to My Research

Covid-19: What do we know about “long covid”?

BMJ (Online), 2020-07, Vol.370, p.m2815-m2815 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m2815

Full text available

Citations Cited by
38
Medical error—the third leading cause of death in the US
Medical error—the third leading cause of death in the US
Material Type:
Article 		Add to My Research

Medical error—the third leading cause of death in the US

BMJ (Online), 2016-05, Vol.353, p.i2139-i2139 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Copyright BMJ Publishing Group LTD May 3, 2016 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i2139 ;PMID: 27143499

Full text available

Citations Cited by
39
Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis
Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis

BMJ (Online), 2016-09, Vol.354, p.i5130-i5130 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright BMJ Publishing Group LTD Sep 28, 2016 ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2016 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i5130 ;PMID: 27683246

Full text available

Citations Cited by
40
Covid-19: New coronavirus variant is identified in UK
Covid-19: New coronavirus variant is identified in UK
Material Type:
Article 		Add to My Research

Covid-19: New coronavirus variant is identified in UK

BMJ (Online), 2020-12, Vol.371, p.m4857-m4857 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m4857 ;PMID: 33328153

Full text available

Citations Cited by

Results 21 - 40 of 184,144  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1960  (36,478)
  2. 1960 To 1975  (32,948)
  3. 1976 To 1991  (38,727)
  4. 1992 To 2008  (39,158)
  5. After 2008  (36,834)
  6. More options open sub menu

Resource Type 

  1. Articles  (183,901)
  2. Reviews  (243)
  3. More options open sub menu

Subject 

  1. Life Sciences & Biomedicine  (184,143)
  2. Science & Technology  (184,143)
  3. General & Internal Medicine  (184,135)
  4. Medicine, General & Internal  (184,135)
  5. Humans  (87,312)
  6. Correspondence  (56,916)
  7. Female  (24,058)
  8. Male  (17,003)
  9. Letter  (15,227)
  10. United Kingdom  (14,103)
  11. Adult  (12,725)
  12. Old Medline  (12,330)
  13. News  (12,013)
  14. Middle Aged  (10,104)
  15. Letters  (9,162)
  16. Aged  (8,373)
  17. Infections  (8,023)
  18. Pregnancy  (7,903)
  19. Physicians  (7,696)
  20. Children  (7,416)
  21. More options open sub menu

Language 

  1. Japanese  (2,875)
  2. Norwegian  (14)
  3. Russian  (6)
  4. French  (3)
  5. German  (2)
  6. Polish  (1)
  7. Italian  (1)
  8. Romanian  (1)
  9. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait